But sometimes life throws us curveballs, like a major health issue. It's no fun to navigate treatment for cancer or other ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies.

SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline ...

Liver cancer is uncommon in the United States, but it is common worldwide due to risk factors such as chronic hepatitis B and C infections and exposure to aflatoxin (toxins produced by a certain ...

Similarly, a previous study (3) analyzed pancreatic cancer samples, identifying TLS-associated marker ... E-TLS density in the IM region and TNM stage emerged as independent prognostic factors. Immune ...

BACKGROUND: Pancreatic neuroendocrine tumors (PNETs) are uncommon and heterogeneous neoplasms, often exhibiting indolent biological behavior. Their incidence is rising, largely due to the widespread ...

Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five years after diagnosis; for women it is 14%. In pancreatic cancer ...

The National Comprehensive Cancer Network recommends that all patients with pancreatic adenocarcinoma get genetic testing. When in doubt, talk with your doctor about your personal and family ...

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...